迅速医療診断キット市場レポート：2030年までの動向、予測、競合分析

迅速医療診断キットの動向と予測

世界の迅速医療診断キット市場は、2024年から2030年までのCAGRが5.5％で、2030年までに推定320億米ドルに達すると予測されます。この市場の主な促進要因は、ポイントオブケア診断の必要性に対する意識の高まり、慢性疾患の迅速な医療診断、感染症患者数の増加です。世界の迅速医療診断キット市場の将来は、病院・診療所、在宅医療、診断ラボ市場での機会により有望視されています。

迅速医療診断キット市場の洞察

Lucintelは、血糖値検査が予測期間中最大セグメントであり続けると予測しています。これは、いくつかの迅速血糖値検査が利用可能であり、それらが広く使用されていることが、このセグメントの成長の主な原動力となっているためです。

北米は、地域住民の間で糖尿病やその他の疾病の発生率が高いこと、医療分野に対する社会的知識の高まりや患者のニーズがますます高まっていることから、予測期間中も最大地域であり続けるでしょう。

よくある質問

Q1.市場規模は？

A1.世界の迅速医療診断キット市場は、2030年までに推定320億米ドルに達すると予想されています。

Q2.市場の成長予測は？

A2.世界の迅速医療診断キット市場は、2024年から2030年にかけてCAGR 5.5%で成長すると予測されます。

Q3.市場の成長に影響を与える主な促進要因は？

A3.この市場の主な促進要因は、ポイントオブケア診断の必要性に対する意識の高まり、慢性疾患の迅速な医療診断、感染症患者数の増加です。

Q4.市場の主要セグメントは？

A4.世界の医療用迅速診断キット市場の将来は、病院・診療所、在宅医療、診断ラボ市場に機会があり、有望です。

Q5.市場の主要企業は？

A5.迅速医療診断キットの主要企業は以下の通り。

• ACON Laboratories
• Abbott
• Artron Laboratories
• Alfa Scientific Designs
• BD
• bioMerieux
• BTNX
• Bio-Rad Laboratories
• Danaher
• Cardinal Health

Q6.今後、最大となる市場セグメントは？

A6.Lucintelは、血糖値検査が予測期間中最大のセグメントであり続けると予測しています。これは、いくつかの迅速な血糖値検査が利用可能であり、それらが広く使用されていることが、このセグメントの成長の主な原動力となっているためです。

Q7.市場において、今後5年間に最大になると予想される地域は？

A7.北米は、糖尿病やその他の疾病の罹患率が高い地域であり、ヘルスケア分野に対する一般的な知識の高まりや患者のニーズがますます高まっていることから、予測期間中も最大地域であり続けると思われます。

Q8.レポートのカスタマイズは可能？

A8.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の迅速医療診断キット市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の迅速医療診断キット市場動向（2018-2023）と予測（2024-2030）
• 製品別の世界の迅速医療診断キット市場
  • 店頭キット
  • プロフェッショナルキット
• 技術別の世界の迅速医療診断キット市場
  • ラテラルフロー法
  • 凝集
  • 固相
  • その他
• アプリケーション別の世界の迅速医療診断キット市場
  • 血糖検査
  • 感染症検査
  • 心臓代謝検査
  • 妊娠と生殖能力の検査
  • 便潜血検査
  • 凝固検査
  • 毒性試験
  • 脂質プロファイル検査
  • その他
• 最終用途別の世界の迅速医療診断キット市場
  • 病院と診療所
  • 在宅医療
  • 診断ラボ

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界の迅速医療診断キット市場
• 北米の迅速医療診断キット市場
• 欧州の迅速医療診断キット市場
• アジア太平洋の迅速医療診断キット市場
• その他地域の迅速医療診断キット市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会の分析
  • 製品別の世界の迅速医療診断キット市場の成長機会
  • 技術別の世界の迅速医療診断キット市場の成長機会
  • アプリケーション別の世界の迅速医療診断キット市場の成長機会
  • 最終用途別の世界の迅速医療診断キット市場の成長機会
  • 地域別の世界の迅速医療診断キット市場の成長機会
• 世界の迅速医療診断キット市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の迅速医療診断キット市場の能力拡大
  • 世界の迅速医療診断キット市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• ACON Laboratories
• Abbott
• Artron Laboratories
• Alfa Scientific Designs
• BD
• bioMerieux
• BTNX
• Bio-Rad Laboratories
• Danaher
• Cardinal Health

Rapid Medical Diagnostic Kit Trends and Forecast

The future of the global rapid medical diagnostic kit market looks promising with opportunities in the hospitals & clinics, home care, and diagnostic laboratory markets. The global rapid medical diagnostic kit market is expected to reach an estimated $32.0 billion by 2030 with a CAGR of 5.5% from 2024 to 2030. The major drivers for this market are the growing awareness of the need for point-of-care diagnostics, quick medical diagnosis of chronic illnesses, and rising numbers of infectious illness cases.

A more than 150-page report is developed to help in your business decisions.

Rapid Medical Diagnostic Kit by Segment

The study includes a forecast for the global rapid medical diagnostic kit by product, technology, application, end use, and region.

Rapid Medical Diagnostic Kit Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Over The Counter Kits
• Professional Kits

Rapid Medical Diagnostic Kit Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Lateral Flow
• Agglutination
• Solid Phase
• Others

Rapid Medical Diagnostic Kit Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Blood Glucose Testing
• Infectious Disease Testing
• Cardiometabolic Testing
• Pregnancy And Fertility Testing
• Fecal Occult Blood Testing
• Coagulation Testing
• Toxicology Testing
• Lipid Profile Testing
• Others

Rapid Medical Diagnostic Kit Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Home Care
• Diagnostic Laboratories

Rapid Medical Diagnostic Kit Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Rapid Medical Diagnostic Kit Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies rapid medical diagnostic kit companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the rapid medical diagnostic kit companies profiled in this report include-

• ACON Laboratories
• Abbott
• Artron Laboratories
• Alfa Scientific Designs
• BD
• bioMerieux
• BTNX
• Bio-Rad Laboratories
• Danaher
• Cardinal Health

Rapid Medical Diagnostic Kit Market Insights

Lucintel forecasts that blood glucose testing will remain the largest segment over the forecast period due to the availability of several quick blood glucose tests and their widespread use are the main drivers of the segment's growth.

North America will remain the largest region over the forecast period because of high rates of diabetes and other illnesses among the local populace, as well as, growing public knowledge of the healthcare sector and patients' ever-increasing needs.

Features of the Global Rapid Medical Diagnostic Kit Market

Market Size Estimates: Rapid medical diagnostic kit market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Rapid medical diagnostic kit market size by various segments, such as by product, technology, application, end use, and region in terms of value ($B).

Regional Analysis: Rapid medical diagnostic kit market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, technology, application, end use, and regions for the rapid medical diagnostic kit market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the rapid medical diagnostic kit market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the rapid medical diagnostic kit market size?

Answer: The global rapid medical diagnostic kit market is expected to reach an estimated $32.0 billion by 2030.

Q2. What is the growth forecast for rapid medical diagnostic kit market?

Answer: The global rapid medical diagnostic kit market is expected to grow with a CAGR of 5.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the rapid medical diagnostic kit market?

Answer: The major drivers for this market are the growing awareness of the need for point-of-care diagnostics, quick medical diagnosis of chronic illnesses, and rising numbers of infectious illness cases.

Q4. What are the major segments for rapid medical diagnostic kit market?

Answer: The future of the global rapid medical diagnostic kit market looks promising with opportunities in the hospitals & clinics, home care, and diagnostic laboratory markets.

Q5. Who are the key rapid medical diagnostic kit market companies?

Answer: Some of the key rapid medical diagnostic kit companies are as follows.

• ACON Laboratories
• Abbott
• Artron Laboratories
• Alfa Scientific Designs
• BD
• bioMerieux
• BTNX
• Bio-Rad Laboratories
• Danaher
• Cardinal Health

Q6. Which rapid medical diagnostic kit market segment will be the largest in future?

Answer: Lucintel forecasts that blood glucose testing will remain the largest segment over the forecast period due to the availability of several quick blood glucose tests and their widespread use are the main drivers of the segment's growth.

Q7. In rapid medical diagnostic kit market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period because of high rates of diabetes and other illnesses among the local populace, as well as, growing public knowledge of the healthcare sector and patients' ever-increasing needs.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the rapid medical diagnostic kit market by product (over the counter kits and professional kits), technology (lateral flow, agglutination, solid phase, and others), application (blood glucose testing, infectious disease testing, cardiometabolic testing, pregnancy and fertility testing, fecal occult blood testing, coagulation testing, toxicology testing, lipid profile testing, and others), end use (hospitals & clinics, home care, and diagnostic laboratories), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Rapid Medical Diagnostic Kit Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Rapid Medical Diagnostic Kit Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Rapid Medical Diagnostic Kit Market by Product
  • 3.3.1: Over the Counter Kits
  • 3.3.2: Professional Kits
• 3.4: Global Rapid Medical Diagnostic Kit Market by Technology
  • 3.4.1: Lateral Flow
  • 3.4.2: Agglutination
  • 3.4.3: Solid Phase
  • 3.4.4: Others
• 3.5: Global Rapid Medical Diagnostic Kit Market by Application
  • 3.5.1: Blood Glucose Testing
  • 3.5.2: Infectious Disease Testing
  • 3.5.3: Cardiometabolic Testing
  • 3.5.4: Pregnancy and Fertility Testing
  • 3.5.5: Fecal Occult Blood Testing
  • 3.5.6: Coagulation Testing
  • 3.5.7: Toxicology Testing
  • 3.5.8: Lipid Profile Testing
  • 3.5.9: Others
• 3.6: Global Rapid Medical Diagnostic Kit Market by End Use
  • 3.6.1: Hospitals & Clinics
  • 3.6.2: Home Care
  • 3.6.3: Diagnostic Laboratories

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Rapid Medical Diagnostic Kit Market by Region
• 4.2: North American Rapid Medical Diagnostic Kit Market
  • 4.2.1: North American Rapid Medical Diagnostic Kit Market by Application: Blood Glucose Testing, Infectious Disease Testing, Cardiometabolic Testing, Pregnancy and Fertility Testing, Fecal Occult Blood Testing, Coagulation Testing, Toxicology Testing, Lipid Profile Testing, and Others
  • 4.2.2: North American Rapid Medical Diagnostic Kit Market by End Use: Hospitals & Clinics, Home Care, and Diagnostic Laboratories
• 4.3: European Rapid Medical Diagnostic Kit Market
  • 4.3.1: European Rapid Medical Diagnostic Kit Market by Application: Blood Glucose Testing, Infectious Disease Testing, Cardiometabolic Testing, Pregnancy and Fertility Testing, Fecal Occult Blood Testing, Coagulation Testing, Toxicology Testing, Lipid Profile Testing, and Others
  • 4.3.2: European Rapid Medical Diagnostic Kit Market by End Use: Hospitals & Clinics, Home Care, and Diagnostic Laboratories
• 4.4: APAC Rapid Medical Diagnostic Kit Market
  • 4.4.1: APAC Rapid Medical Diagnostic Kit Market by Application: Blood Glucose Testing, Infectious Disease Testing, Cardiometabolic Testing, Pregnancy and Fertility Testing, Fecal Occult Blood Testing, Coagulation Testing, Toxicology Testing, Lipid Profile Testing, and Others
  • 4.4.2: APAC Rapid Medical Diagnostic Kit Market by End Use: Hospitals & Clinics, Home Care, and Diagnostic Laboratories
• 4.5: ROW Rapid Medical Diagnostic Kit Market
  • 4.5.1: ROW Rapid Medical Diagnostic Kit Market by Application: Blood Glucose Testing, Infectious Disease Testing, Cardiometabolic Testing, Pregnancy and Fertility Testing, Fecal Occult Blood Testing, Coagulation Testing, Toxicology Testing, Lipid Profile Testing, and Others
  • 4.5.2: ROW Rapid Medical Diagnostic Kit Market by End Use: Hospitals & Clinics, Home Care, and Diagnostic Laboratories

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Rapid Medical Diagnostic Kit Market by Product
  • 6.1.2: Growth Opportunities for the Global Rapid Medical Diagnostic Kit Market by Technology
  • 6.1.3: Growth Opportunities for the Global Rapid Medical Diagnostic Kit Market by Application
  • 6.1.4: Growth Opportunities for the Global Rapid Medical Diagnostic Kit Market by End Use
  • 6.1.5: Growth Opportunities for the Global Rapid Medical Diagnostic Kit Market by Region
• 6.2: Emerging Trends in the Global Rapid Medical Diagnostic Kit Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Rapid Medical Diagnostic Kit Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Rapid Medical Diagnostic Kit Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: ACON Laboratories
• 7.2: Abbott
• 7.3: Artron Laboratories
• 7.4: Alfa Scientific Designs
• 7.5: BD
• 7.6: bioMerieux
• 7.7: BTNX
• 7.8: Bio-Rad Laboratories
• 7.9: Danaher
• 7.10: Cardinal Health